Clinical trial
A Glycemic Control Evaluation of Glimepiride Versus Rimonabant on Top of…
NCT00449605 · Sanofi, Industry · Terminated
Key facts
| NCT number | NCT00449605 |
|---|---|
| Title | A Glycemic Control Evaluation of Glimepiride Versus Rimonabant on Top of Metformin in Type 2 Diabetes |
| Official title | A Randomized, Double-Blind, Parallel-Group, Multicenter, Multinational Study to Assess Glycemic Control With Rimonabant in Comparison With Glimepiride Over 1 Year in Overweight/Obese Type2 Diabetic Patients Not Adequately Controlled With Metformin |
| Acronym | ALLEGRO |
| Lead sponsor | Sanofi, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Rimonabant, Glimepiride, Metformin |
| Enrollment | 508 |
| Start date | Mar 1, 2007 |
| Primary completion | Nov 1, 2008 |
| Completion | Mar 1, 2009 |
| First posted | Mar 20, 2007 |
| Last update posted | May 16, 2016 |
| Countries | Chile, Denmark, Finland, Hungary, India, Italy, Mexico, Puerto Rico, Romania, Russia, South Korea, Spain and 2 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: